Cara Therapeutics Study Site

Kansas City, Missouri 64111

We've found

2 trials

at this facility

A Study to Evaluate the Safety and Efficacy of CR845 in Chronic Kidney Disease Patients With Moderate-to-Severe Pruritus

Status: Enrolling, Phase II
Updated: 12/31/1969

from

Kansas City, MO

Extension Study to Evaluate IV CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus

Status: Enrolling, Phase III
Updated: 12/31/1969

from

Kansas City, MO

Use our guide to learn which trials are right for you!